Last Updated on October 6, 2024 by The Health Master
The drug regulator of India has approved the extension of shelf life of Bharat Biotech‘s Covid-19 vaccine Covaxin up to 12 months.
The company today announced that it has received the approval from the Central Drugs Standard Control Organisation (CDSCO) for the extension of shelflife of the vaccine up to 12 months, from the date of manufacture.
“This approval of shelf life extension is based on the availability of additional data, which was submitted to CDSCO,” added the Hyderabad-based company.
The vaccine was initially approved by the drug regulator for a shelf life of six months, when stored at two to eight degree celsius. It was later extended to nine months.
The longer shelf life is expected to help optimise and improve the use of vaccine.
Pharma sector seek Govt to decriminalize errors by Drug Mfrs in…
Latest Anti-counterfeiting packaging for Pharma Sector
Why Indians have more trust their nearby Medical Store
USFDA nod for Cortrophin Gel to treat Autoimmune Disorders
WHO approves Indian Firm Bharat Biotech’s Covaxin
FDA cancels licenses of 2 Blood Cantres, suspends 12 firms
Duties of Retail Chemists / Medical Store / Pharmacy
Govt to plan to conduct these 8 studies on Pharma & Medical Devices
Govt takes important decisions on Pharma & Medical Devices Industry
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
